Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

par Taskinen, Marja-Riitta, Borén, Jan
Publié dans Curr Atheroscler Rep (2016)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

par Taskinen, Marja-Riitta, Packard, Chris J., Borén, Jan
Publié dans Curr Atheroscler Rep (2019)

Dietary Fructose and the Metabolic Syndrome

par Taskinen, Marja-Riitta, Packard, Chris J, Borén, Jan
Publié dans Nutrients (2019)

Causes and Consequences of Hypertriglyceridemia

par Packard, Chris J., Boren, Jan, Taskinen, Marja-Riitta
Publié dans Front Endocrinol (Lausanne) (2020)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

par Borén, Jan, Packard, Chris J., Taskinen, Marja-Riitta
Publié dans Front Endocrinol (Lausanne) (2020)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

par Shuhei, Nakanishi, Söderlund, Sanni, Jauhiainen, Matti, Taskinen, Marja-Riitta
Publié 2010

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

par Adiels, Martin, Mardinoglu, Adil, Taskinen, Marja-Riitta, Borén, Jan
Publié dans Front Physiol (2015)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

par Kahri, Juhani, Soro-Paavonen, Aino, Ehnholm, Christian, Taskinen, Marja-Riitta
Publié 2006

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

par Krengel, Annette, Hauth, Jan, Taskinen, Marja-Riitta, Adiels, Martin, Jirstrand, Mats
Publié 2013

Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models

par Berglund, Martin, Adiels, Martin, Taskinen, Marja-Riitta, Borén, Jan, Wennberg, Bernt
Publié dans PLoS One (2015)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

par Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Publié 2010

Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol

par Björnson, Elias, Adiels, Martin, Gummesson, Anders, Taskinen, Marja-Riitta, Burgess, Stephen, Packard, Chris J, Borén, Jan
Publié dans J Am Coll Cardiol (2024)

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized contr...

par Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan
Publié dans Diabetes Obes Metab (2018)

Lipoprotein(a) is Markedly More Atherogenic than LDL: An Apolipoprotein B-based Genetic Analysis

par Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Chapman, M. John, Packard, Chris J, Borén, Jan
Publié dans J Am Coll Cardiol (2024)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

par Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publié 2009

High-resolution population-specific recombination rates and their effect on phasing and genotype imputation

par Hassan, Shabbeer, Surakka, Ida, Taskinen, Marja-Riitta, Salomaa, Veikko, Palotie, Aarno, Wessman, Maija, Tukiainen, Taru, Pirinen, Matti, Palta, Priit, Ripatti, Samuli
Publié dans Eur J Hum Genet (2020)

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality

par Fredriksson, Jenny, Anevski, Dragi, Almgren, Peter, Sjögren, Marketa, Lyssenko, Valeriya, Carlson, Joyce, Isomaa, Bo, Taskinen, Marja-Riitta, Groop, Leif, Orho-Melander, Marju
Publié 2007

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

par Yetukuri, Laxman, Söderlund, Sanni, Koivuniemi, Artturi, Seppänen-Laakso, Tuulikki, Niemelä, Perttu S., Hyvönen, Marja, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Publié 2010

Cardiac steatosis and left ventricular function in men with metabolic syndrome

par Nyman, Kristofer, Granér, Marit, Pentikäinen, Markku O, Lundbom, Jesper, Hakkarainen, Antti, Sirén, Reijo, Nieminen, Markku S, Taskinen, Marja-Riitta, Lundbom, Nina, Lauerma, Kirsi
Publié 2013

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

par Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Publié 2010